These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27790711)

  • 1. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
    Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
    Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
    Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
    de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
    Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
    Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.
    Takeda H; Wei Z; Koso H; Rust AG; Yew CC; Mann MB; Ward JM; Adams DJ; Copeland NG; Jenkins NA
    Nat Genet; 2015 Feb; 47(2):142-50. PubMed ID: 25559195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
    Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
    Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
    Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
    PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
    Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.
    Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA
    Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.
    Rojas A; Meherem S; Kim YH; Washington MK; Willis JE; Markowitz SD; Grady WM
    Int J Cancer; 2008 Jul; 123(1):14-21. PubMed ID: 18425817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.
    Starr TK; Allaei R; Silverstein KA; Staggs RA; Sarver AL; Bergemann TL; Gupta M; O'Sullivan MG; Matise I; Dupuy AJ; Collier LS; Powers S; Oberg AL; Asmann YW; Thibodeau SN; Tessarollo L; Copeland NG; Jenkins NA; Cormier RT; Largaespada DA
    Science; 2009 Mar; 323(5922):1747-50. PubMed ID: 19251594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
    Janik CL; Starr TK
    J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.